Invitrogen™ Human CDIP1 Synthetic Peptide
CDIP Synthetic Peptide, PEP-0812, from Invitrogen.
- Gene ID (Enter)
- 29965
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9H305
- Common name
- Human CDIP1
- Brand
- Invitrogen
CDIP Synthetic Peptide, PEP-0812, from Invitrogen.
CDIP Synthetic Peptide, PEP-0812, from Invitrogen.
The p53 tumor-suppressor gene integrates numerous signals that control cell life and death; loss of its functions contributes to the development of most cancers. CDIP is a novel pro-apoptotic target gene whose inhibition abrogates p53-mediated apoptotic responses. Overexpression of CDIP induced apoptosis in transfected cells while siRNA suppression of caspase-8 mRNA blocked this CDIP-induced apoptosis, indicating that the CDIP-dependent apoptosis pathway proceeds through extrinsic cell death pathway. CDIP may thus represent a novel target for drug design to maximize p53 response and sensitize tumor cells to cancer therapy. Multiple isoforms of CDIP are known to exist.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15369040 |
| Specifications | |
| Gene ID (Enter) | 29965 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9H305 |
| Common name | Human CDIP1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | CDIP1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0812 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |